Role of tumor-associated macrophages in the progression of hepatocellular carcinoma
- PMID: 22116397
- DOI: 10.1007/s00595-011-0058-8
Role of tumor-associated macrophages in the progression of hepatocellular carcinoma
Abstract
Recent studies have shown that the tumor microenvironment plays an important role in cancer progression. Tumor-associated macrophages (TAMs), in particular, have been found to be associated with tumor progression. Macrophages have multiple biological roles, including antigen presentation, target cell cytotoxicity, removal of foreign bodies, tissue remodeling, regulation of inflammation, induction of immunity, thrombosis, and endocytosis. Recent immunological studies have identified two distinct states of polarized macrophage activation: the classically activated (M1) and the alternatively activated (M2) macrophage phenotypes. Bacterial moieties such as lipopolysaccharides and the Th1 cytokine interferon-γ polarize macrophages toward the M1 phenotype. The M2 polarization was discovered as a response to the Th2 cytokine interleukin-4. In general, M2 macrophages exert immunoregulatory activity, participate in polarized Th2 responses, and aid tumor progression. TAMs have recently been found to play an important role in hepatocellular carcinoma (HCC) progression. Based on the properties of TAMs, obtained from pathological examination of resected specimens, we have identified new therapeutic approaches, involving the targeting of TAMs with adjuvant therapy after hepatic resection for HCC. This review discusses the roles of TAM in HCC progression and the possibility of new therapies targeting TAMs.
Similar articles
-
Individualized precision treatment: Targeting TAM in HCC.Cancer Lett. 2019 Aug 28;458:86-91. doi: 10.1016/j.canlet.2019.05.019. Epub 2019 May 24. Cancer Lett. 2019. PMID: 31129147 Review.
-
Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review).Int J Oncol. 2024 Oct;65(4):100. doi: 10.3892/ijo.2024.5688. Epub 2024 Sep 6. Int J Oncol. 2024. PMID: 39239752 Free PMC article. Review.
-
Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.Cell Death Dis. 2018 Jul 18;9(8):793. doi: 10.1038/s41419-018-0818-0. Cell Death Dis. 2018. PMID: 30022048 Free PMC article.
-
Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8+ T cells in hepatocellular carcinoma.J Hepatol. 2024 Oct;81(4):690-703. doi: 10.1016/j.jhep.2024.05.007. Epub 2024 May 15. J Hepatol. 2024. PMID: 38759889
-
Macrophages as Targets in Hepatocellular Carcinoma Therapy.Mol Cancer Ther. 2024 Jun 4;23(6):780-790. doi: 10.1158/1535-7163.MCT-23-0660. Mol Cancer Ther. 2024. PMID: 38310642 Review.
Cited by
-
CCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model.PLoS One. 2013 Dec 5;8(12):e81065. doi: 10.1371/journal.pone.0081065. eCollection 2013. PLoS One. 2013. PMID: 24339898 Free PMC article.
-
Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection.BMC Cancer. 2014 Oct 3;14:744. doi: 10.1186/1471-2407-14-744. BMC Cancer. 2014. PMID: 25280428 Free PMC article.
-
SJSZ glycoprotein (38 kDa) modulates macrophage type 1/2-related factors at hepatocarcinogenic stage in N-nitrosodiethylamine-treated Balb/c.Mol Cell Biochem. 2013 Jan;372(1-2):17-26. doi: 10.1007/s11010-012-1441-5. Epub 2012 Sep 7. Mol Cell Biochem. 2013. PMID: 22956448
-
Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysis.Surg Today. 2017 Mar;47(3):385-392. doi: 10.1007/s00595-016-1384-7. Epub 2016 Jul 27. Surg Today. 2017. PMID: 27465474
-
Systematic analysis of TREM2 and its carcinogenesis in pancreatic cancer.Transl Cancer Res. 2024 Jul 31;13(7):3200-3216. doi: 10.21037/tcr-24-201. Epub 2024 Jul 24. Transl Cancer Res. 2024. PMID: 39145088 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical